Co-Diagnostics Inc

C97

Company Profile

  • Business description

    Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

  • Contact

    2401 South Foothill Drive
    Salt Lake CityUT84109
    USA

    T: +1 801 438-1036

    https://www.codiagnostics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    132

Stocks News & Analysis

stocks

3 global ‘buy the dip’ candidates with wide moats

Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.
stocks

What next for Nine Entertainment after Domain payout?

The media group has excelled in controlling what it can control. Now the focus shifts to capital deployment.
stocks

Are we as bullish on Oracle as the market?

Shares jumped in response to the latest results.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,128.7018.100.20%
CAC 407,825.241.720.02%
DAX 4023,698.155.50-0.02%
Dow JONES (US)45,834.22273.78-0.59%
FTSE 1009,283.2914.29-0.15%
HKSE26,388.16301.841.16%
NASDAQ22,141.1098.030.44%
Nikkei 22544,768.12395.620.89%
NZX 50 Index13,227.901.25-0.01%
S&P 5006,584.293.18-0.05%
S&P/ASX 2008,864.9022.000.25%
SSE Composite Index3,870.604.71-0.12%

Market Movers